Review
Reaping the Benefits of Genomic and Proteomic Research: Intellectual Property Rights, Innovation, and Public Health
Washington (DC): National Academies Press (US); 2006.
- PMID: 20669435
- Bookshelf ID: NBK19865
- DOI: 10.17226/11487
Item in Clipboard
Review
Reaping the Benefits of Genomic and Proteomic Research: Intellectual Property Rights, Innovation, and Public Health
Excerpt
Avoiding a conflict between open dissemination and access to scientific discoveries and the protection of inventors' rights is critical to furthering scientific progress and enhancing human health. It also is critical that as science evolves, we stop to assess whether the appropriate mechanisms to prevent such a conflict remain in place. This report is just such an assessment—a marker in time that looks at the state of genomic and proteomic research and the current policies and practices promoting or restricting the dissemination of scientific information, tools, and products, and asks, "are there any storms over the horizon?"
Copyright © 2006, National Academy of Sciences.
Sections
- The National Academies
- Committee on Intellectual Property Rights in Genomic and Protein Research and Innovation
- Board on Science, Technology, and Economic Policy
- Committee on Science, Technology, and Law
- Preface and Acknowledgments
- Summary
- 1. Introduction
- 2. Genomics, Proteomics, and the Changing Research Environment
- 3. The U.S. Patent System, Biotechnology, and the Courts
- 4. Trends in the Patenting and Licensing of Genomic and Protein Inventions and Their Impact on Biomedical Research
- 5. Conclusions and Recommendations
- References
- Appendixes
Publication types
Grants and funding
This study was supported by Contract No. N01-OD-4-2139, between the National Academies and the National Institutes of Health. In addition, the study was supported by Affymetrix Inc., Agilent Technologies, Amgen, Biotechnology Industry Organization, Chiron Foundation, Pfizer Inc., and the Bellagio Center of the Rockefeller Foundation. The views presented in this report are those of the National Research Council Committee on the Intellectual Property Rights in Genomic and Protein Research and Innovation and are not necessarily those of the funding agencies.
LinkOut - more resources
Full Text Sources
Other Literature Sources
